We serve Chemical Name:4-Bromo-5-methyl-1,3-thiazol-2-amine CAS:1209167-05-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-5-methyl-1,3-thiazol-2-amine
CAS.NO:1209167-05-4
Synonyms:4-Bromo-5-methyl-1,3-thiazol-2-amine;2-Thiazolamine, 4-bromo-5-methyl-
Molecular Formula:C4H5BrN2S
Molecular Weight:193.065
HS Code:2934100090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:298.3±20.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.661
PSA:67.88000
Exact Mass:191.935669
LogP:1.61
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Bromo-5-methyl-1,3-thiazol-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Thiazolamine, 4-bromo-5-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Thiazolamine, 4-bromo-5-methyl- Use and application,2-Thiazolamine, 4-bromo-5-methyl- technical grade,usp/ep/jp grade.
Related News: Global demand has skyrocketed over the last year for scalable services that support employee well-being and development, and further strengthen mental fitness for individuals. This demand has recently been substantiated by peer-reviewed research, which illuminates the power of AI-enabled coaching, and its ability to improve psychological well-being while mitigating threats to mental health. 2,2′,3,3′-Tetrahydro-1,1′-spirobi[indene]-7,7′-diol manufacturers The new R&D People and Culture Strategy aims to make UK the most ideal place for research and innovation, led by individuals, universities and businesses, and funders. sodium,2-[methyl(tetradecanoyl)amino]ethanesulfonate suppliers A new post-hoc analysis of pooled data from the TULIP phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR 2021) showed anifrolumab was consistently associated with improvements in both skin rash and arthritis across three different disease measures each, compared to placebo, in patients with moderate to severe systemic lupus erythematosus (SLE). 2-Ethylhexyl 4-Hydroxybenzoate vendor & factory.
